274 related articles for article (PubMed ID: 26686802)
21. A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.
Campbell JA; Palmer AJ; Venn A; Sharman M; Otahal P; Neil A
Patient; 2016 Aug; 9(4):311-22. PubMed ID: 26841910
[TBL] [Abstract][Full Text] [Related]
22. Mapping algorithms from QLQ-C30 to EQ-5D utilities: no firm ground to stand on yet.
Crott R
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):569-76. PubMed ID: 24910212
[TBL] [Abstract][Full Text] [Related]
23. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.
Kim EJ; Ko SK; Kang HY
Qual Life Res; 2012 Sep; 21(7):1193-203. PubMed ID: 22012023
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death.
Hatswell AJ; Pennington B; Pericleous L; Rowen D; Lebmeier M; Lee D
Health Qual Life Outcomes; 2014 Sep; 12():140. PubMed ID: 25214238
[TBL] [Abstract][Full Text] [Related]
25. Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma.
Arnold DT; Rowen D; Versteegh MM; Morley A; Hooper CE; Maskell NA
Health Qual Life Outcomes; 2015 Jan; 13():6. PubMed ID: 25613110
[TBL] [Abstract][Full Text] [Related]
26. Health-Related Quality of Life of Patients with HIV/AIDS in Bogotá, Colombia.
Keaei M; Kuhlmann J; Conde R; Evers SM; Gonzalez J; Govers M; Hiligsmann M
Value Health Reg Issues; 2016 Dec; 11():68-72. PubMed ID: 27986201
[TBL] [Abstract][Full Text] [Related]
27. Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study.
Long GV; Atkinson V; Ascierto PA; Robert C; Hassel JC; Rutkowski P; Savage KJ; Taylor F; Coon C; Gilloteau I; Dastani HB; Waxman IM; Abernethy AP
Ann Oncol; 2016 Oct; 27(10):1940-6. PubMed ID: 27405322
[TBL] [Abstract][Full Text] [Related]
28. Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients.
Kim SH; Jo MW; Kim HJ; Ahn JH
Health Qual Life Outcomes; 2012 Dec; 10():151. PubMed ID: 23244763
[TBL] [Abstract][Full Text] [Related]
29. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
Doble B; Lorgelly P
Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life in patients with melanoma expressed as utilities and disability weights.
Tromme I; Devleesschauwer B; Beutels P; Richez P; Leroy A; Baurain JF; Cornelis F; Bertrand C; Legrand N; Degueldre J; Thomas L; Legrand C; Lambert J; Haagsma J; Speybroeck N
Br J Dermatol; 2014 Dec; 171(6):1443-50. PubMed ID: 25039853
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
32. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial.
Devlin N; Herdman M; Pavesi M; Phung D; Naidoo S; Beer TM; Tombal B; Loriot Y; Ivanescu C; Parli T; Balk M; Holmstrom S
Health Qual Life Outcomes; 2017 Jun; 15(1):130. PubMed ID: 28645287
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment.
Bergius S; Torvinen S; Muhonen T; Roine RP; Sintonen H; Taari K
Scand J Urol; 2017 Feb; 51(1):13-19. PubMed ID: 27809631
[TBL] [Abstract][Full Text] [Related]
35. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
36. Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences.
Crott R; Briggs A
Eur J Health Econ; 2010 Aug; 11(4):427-34. PubMed ID: 20473703
[TBL] [Abstract][Full Text] [Related]
37. Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study.
Hagiwara Y; Shiroiwa T; Shimozuma K; Kawahara T; Uemura Y; Watanabe T; Taira N; Fukuda T; Ohashi Y; Mukai H
Pharmacoeconomics; 2018 Feb; 36(2):215-223. PubMed ID: 29043567
[TBL] [Abstract][Full Text] [Related]
38. Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of Cancer.
Stockler MR; Osoba D; Goodwin P; Corey P; Tannock IF
J Clin Epidemiol; 1998 Feb; 51(2):137-45. PubMed ID: 9474074
[TBL] [Abstract][Full Text] [Related]
39. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.
Swinburn P; Lloyd A; Boye KS; Edson-Heredia E; Bowman L; Janssen B
Value Health; 2013 Dec; 16(8):1156-62. PubMed ID: 24326169
[TBL] [Abstract][Full Text] [Related]
40. Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.
Lorgelly PK; Doble B; Rowen D; Brazier J;
Qual Life Res; 2017 May; 26(5):1163-1176. PubMed ID: 27830513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
